Sponsor:
Fortvita Biologics (USA)Inc.
Code:
NCT07842393
Conditions
Healthy Volunteers (HV)
Eligibility Criteria
Sex: All
Age: 18 - 55
Healthy Volunteers: Accepted
Interventions
Investigational Drug: IBI3042
Matching Placebo
Brief summary:
Conditions
Healthy Volunteers (HV)
Study ID
NCT07842393
Start date
Oct 20, 2026
Status verified date
Nov, 2026
Completion date
Mar 2, 2027
Anticipated
Primary completion date
Mar 2, 2027
Anticipated
Eligibility Criteria
Sex: All
Age: 18 - 55
Healthy Volunteers: Accepted
Enrollment
32 participants
Anticipated
Allocation
Randomized
Intervention Model
Sequential
Primary purpose
Treatment
Arms
placebo comparator: Matching Placebo
experimental: Investigational Drug: IBI3042
Interventions
Investigational Drug: IBI3042
Matching Placebo
Primary outcome measure
Central contacts
Locations
ICON Lenexa
Recruiting
Lenexa, Kansas, United States, 66219
Contacts
Principal Investigator:
Pactrick Yao, PhD
Sponsor
Fortvita Biologics (USA)Inc.
Last update posted
Nov 20, 2026
Last verified
Nov, 2026
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-11-21. This information was provided to ClinicalTrials.gov by Fortvita Biologics (USA)Inc. on 2026-11-20. Recruitment status is synced daily from ClinicalTrials.gov and may not reflect the sponsor's current status. Confirm during your call.